Cross border acquisitions and R&D activities: a comparative study in the Italian red biotech industry Online publication date: Wed, 13-Sep-2017
by Michela Matarazzo; Biagio Merola; Riccardo Resciniti
Global Business and Economics Review (GBER), Vol. 19, No. 5, 2017
Abstract: In fast growing markets, technology-grafting acquisitions provide rapid and exclusive access to technologies and capabilities of the acquired firm. This paper focuses on the impact of cross border acquisitions on R&D activities of the target firms in order to answer these research questions: are these firms in the post-acquisition stage more innovative? What are the main reasons? Four Red biotech acquired companies are used as multiple case study. Results suggest that the target companies take advantage of the acquisition in terms of: a boost to their R&D activities; R&D synergies with the buyer; developments of their research and growth in sales worldwide. Managers may benefit from a mutual exchange of knowledge and competences between acquired firms and MNEs. Policy makers should encourage FDI attraction strategies. This study for the first time analyses the post-acquisition innovation performance of all the Italian acquired mid-sized firms.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the Global Business and Economics Review (GBER):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook